HOME

ABOUT US

QUALITY FACTOR

LAB TESTS AVAILABLE

USEFUL LINKS

Hemostasis Reference Laboratory logo

The Quality Factor in Hemostasis Testing

   
pipettes

 

 

 

 

 

The Hemostasis Reference Laboratory (HRL) is a Canadian Laboratory that is accredited by the College of American Pathologists (CAP) and works to the International Standard of ISO 15189: Medical laboratories -- Particular requirements for quality and competence.

We are located in the Henderson Research Centre in Hamilton, Ontario, a centre of excellence for the diagnosis and treatment of thrombosis.

We offer pharmaceutical companies, diagnostic manufacturers, and researchers a complete range of testing for clinical trials, research projects and product evaluation.

Our expertise is in the measurement of routine and esoteric coagulation, fibrinolytic, cytokine testing and DNA analysis.

If you require another test parameter, we have the facilities to develop and validate new assays.

Hemostasis Reference Laboratory

Henderson Research Centre,

40 Wing, Ground Floor

711 Concession Street,

Hamilton, Ontario L8V 1C3

CANADA

Telephone: 905-527-2299 ext 42667

888-660-0999

Fax: 905-575-2647

 

News and Upcoming Events

NOW AVAILABLE!!

Microparticle Activity Analysis

For more information see our News and Upcoming Events page.

Genotyping for Warfarin Therapy

Cytochrome P450 2C9 gene (CYP2C9) & Vitamin K Epoxide Reductase Complex 1 gene (VKORC1) genotyping is now available. For more information see our News and Upcoming Events page.

Molecular Cancer Therapeutics Article

HRL is pleased to inform of a publication by Lucy Shin, the recipient of the HRL Scholarship for 2006, titled "Effects of the chemotherapeutic agent doxorubicon on the protein C anticoagulant pathway".  For more information see our News and Upcoming Events page.

PROCALCITONIN

Testing

The B·R·A·H·M·S PCT LIA assay has been cleared by the FDA for the early diagnosis of patients at risk for progression to severe sepsis. 

HRL offers Procalcitonin (PCT) testing for research purposes.  The clinical utility in select patient populations has already been identified and continued studies to discover the optimal utilization of this marker as it relates to patient management is foreseen.  The availability of this FDA-cleared PCT assay will encourage further international clinical-scientific studies.

  Click here to view the News and Upcoming Events page.

HOME | ABOUT US | QUALITY FACTOR | LAB TESTS AVAILABLE | USEFUL LINKS